Cargando…
Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
Malignant brain tumors remain uniformly fatal, even with the best-to-date treatment. For Glioblastoma (GBM), the most severe form of brain cancer in adults, the median overall survival is roughly over a year. New therapeutic options are urgently needed, yet recent clinical trials in the field have b...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753120/ https://www.ncbi.nlm.nih.gov/pubmed/33364198 http://dx.doi.org/10.3389/fonc.2020.604121 |